Navigation Links
t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
Date:11/25/2008

FRANKFURT, Germany, November 25 /PRNewswire/ -- t2cure, a biopharmaceutical company developing regenerative medicine therapeutics from a patient's own stem cells, today announced that it has acquired a family of patents and patent applications from Innovectis, the technology transfer arm of Frankfurt University.

The patents cover a technology that allows for the rapid characterization of the potency of bone marrow-derived cells in the treatment of cardiovascular diseases. The potency of stem cells characterizes their potential to induce or perform repair processes in adult tissue. Recent drafts and guidelines from EMEA and FDA have made clear that potency testing will be a key criterion for batch release, and thus for market approval, of stem cell-based therapies.

"This acquisition of patent rights is a significant contribution to our regulatory strategy, as our lead product is advancing into a pivotal Phase III study in acute myocardial infarction," said Manfred Ruediger, CEO t2cure. "These patent rights complement our existing IP portfolio, supporting our commitment to make stem cell-based therapeutics a clinical reality for patients suffering from an acute heart attack or chronic heart failure."

Each year, 40,000 patients are hit by a severe heart attack in Germany alone and many more are suffering from chronic heart disease. Currently there is no treatment available that can reverse the damage to diseased heart muscle. In clinical trials, stem cell-based therapies under development by t2cure have demonstrated the potential to repair damaged tissue.

t2cure will use its technology for potency testing to confirm product specifications in the course of its upcoming pivotal Phase III study in acute myocardial infarction. This study, which will enroll up to 1,400 patients, is scheduled to enroll its first patients in the second quarter of 2009.

About t2cure GmbH


'/>"/>

SOURCE t2cure GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
2. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
3. Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
4. Affitech Acquires Pharmexas Diabody Technology
5. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
6. CPA Acquires Renowned German Patent Research Specialist, SVPG
7. Circassia Acquires North American and Japanese Rights to Dopexamine
8. Advanced Instruments Acquires D & F Control Systems Inc.
9. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
10. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
11. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)...  Having the right people at the table for ... growth and achieving clinical and operational goals. The 22 ... July 20-22, 2014, in San Diego ... healthcare experts discussing how partnerships have positively impacted their ... Chief Executive Officer of Cape Regional Medical Center located ...
(Date:7/23/2014)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... announced that the underwriters of its common stock ... an additional 420,000 shares of common stock at ... less underwriting discounts and commissions, in connection with ... shares of common stock, bringing the expected net ...
(Date:7/23/2014)... 2014 China Cord Blood Corporation (NYSE: CO ... provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, ... multi-product healthcare company catering to the mother and child segment, today ... across the PRC, Singapore , Hong ... , the Philippines and ...
(Date:7/23/2014)... Astra Nova Training , ... and pharma training services, and the Alliance ... a non-profit integrating the expertise and investments of ... global system for clinical trials, are pleased to ... expertise of industry professionals through improved and easily ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... Characterization of nucleotide and nucleoside analogs from Taraxacum mongolicum, ... time using liquid chromatography tandem mass spectrometry (LC/MS/MS). The ... and nucleoside standards with product and precursor scans of ... be major active ingredients which have anti-Herpes simplex virus ...
... A very straightforward method for the analysis of ... oxydemeton-methyl, vamidothion, and monocrotophos in water has been developed. ... onto a RP18 HPLC column with a polar endcapping. ... a tandem mass spectrometer operated in multiple reaction-monitoring mode. ...
... , ... the quantitation of , pesticide residues in food ... very sensitive, selective, and rugged LC/MS/MS technologies. In this , ... is described. In particular the role of the collision cell in the ...
Cached Biology Technology:Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 2Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 3Determination of Polar Organophosphorus Pesticides in Aqueous Samples by Direct Injection Using HPLC/MS/MS 2Fast Multi-Residue Pesticide Analysis in Soil and Vegetable Samples 2Fast Multi-Residue Pesticide Analysis in Soil and Vegetable Samples 3Fast Multi-Residue Pesticide Analysis in Soil and Vegetable Samples 4
(Date:7/23/2014)... lab experiments using tissue samples cultured from cystic fibrosis ... the UNC Marsico Lung Institute have shown that a ... of another CF drug. , The finding, published today ... how a mutant CFTR protein becomes unstable and loses ... of the two drugs. The research offers several insights ...
(Date:7/23/2014)... are disappearing, and though conservationists are examining several possible ... rain and light pollution, a key piece of the ... once they leave their breeding sites, and what threats ... answer this question, a team of researchers out of ... map produced for a songbird, using tracking from both ...
(Date:7/23/2014)... This news release is available in German . ... shape and stability to cells, drive metabolic processes and ... into complex three-dimensional shapes. Scientists at the Max Planck ... that proteins can be constructed of similar amino acid ... suggests that the proteins that exist today arose from ...
Breaking Biology News(10 mins):UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 2UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 3UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies 4York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2Protein evolution follows a modular principle 2
... your baby isn,t destined to a life of obesity after ... The FASEB Journal . In the report, ... during pregnancy to a moderate level is enough to benefit ... that a protein called "SIRT1" rewrites a developing fetus, histone ...
... of emission reduction measures are considerable. In order ... to develop uniform assessment methods for ensuring that ... practice., Significant mitigation of climate change is widely ... considerable reductions in global greenhouse gas emissions in ...
... product secreted by a soil bacterium shows promise as ... a new study published in EMBO Molecular Medicine ... shown how pyridomycin, a natural antibiotic produced by the ... candidate is active against many of the drug-resistant types ...
Cached Biology News:Eating well during pregnancy reduces baby's obesity risk regardless of mom's size 2Effectiveness and impact of climate change mitigation measures unclear 2Effectiveness and impact of climate change mitigation measures unclear 3Scientists reveal how natural antibiotic kills tuberculosis bacterium 2
Anti-gp340 Monoclonal Antibody Description: 100 g Research Focus: cancer & cell proliferation Storage: -20C Shipping Temperature: 4C...
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Biology Products: